MPS-FFA: A multiplane and multiscale feature fusion attention network for Alzheimer's disease prediction with

Fei Liu1, Huabin Wang1, Shiuan-Ni Liang2

  • 1Anhui Provincial International Joint Research Center for Advanced Technology in Medical Imaging, Anhui University, Hefei, China; School of Computer Science and Technology, Anhui University, Hefei, China.

Insights

This study introduces a novel AI model for Alzheimer's disease (AD) diagnosis using structural magnetic resonance imaging (sMRI). The multiplane and multiscale feature-level fusion attention (MPS-FFA) model effectively identifies subtle brain atrophy patterns for improved diagnostic accuracy.

Area of Science:

  • Neuroimaging
  • Artificial Intelligence
  • Medical Diagnostics

Background:

  • Structural magnetic resonance imaging (sMRI) is crucial for Alzheimer's disease (AD) diagnosis, but identifying specific atrophy patterns remains challenging due to inter-patient variability.
  • Existing methods struggle to pinpoint the most discriminating atrophy features in sMRI scans, hindering accurate AD diagnosis.

Purpose of the Study:

  • To develop and validate a novel deep learning model, the multiplane and multiscale feature-level fusion attention (MPS-FFA) model, for enhanced AD diagnosis using sMRI.
  • To improve the identification and localization of discriminating brain atrophy features in sMRI scans for Alzheimer's disease.

Main Methods:

  • The proposed MPS-FFA model employs a feature encoder with multiscale feature extraction and hybrid attention to fuse pathological features across sagittal, coronal, and axial planes.
  • A global attention classifier integrates clinical scores and attention layers to weigh feature importance, while a feature similarity discriminator enhances discrimination of atrophy features.
  • Feature visualization techniques are utilized within the MPS-FFA model to improve interpretability in identifying key diagnostic features.

Main Results:

  • Experimental results on two independent sMRI databases demonstrate the effectiveness of the MPS-FFA model in terms of accuracy and generalizability.
  • The model successfully identified pathological locations associated with Alzheimer's disease, showcasing its capability in precise localization.
  • Improved interpretability was achieved through feature visualization, aiding in the understanding of the model's diagnostic reasoning.

Conclusions:

  • The MPS-FFA model represents a significant advancement in sMRI-based Alzheimer's disease diagnosis by effectively identifying and discriminating subtle atrophy features.
  • The model's multiplane and multiscale approach, combined with attention mechanisms, enhances diagnostic accuracy and generalizability.
  • The developed model offers improved interpretability, facilitating a better understanding of the neuroimaging markers crucial for AD diagnosis.